[1] |
Lyman GH, Carrier M, Ay C, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: Prevention and treatment in patients with cancer[J]. Blood Adv, 2021, 5(4):927-974.
doi: 10.1182/bloodadvances.2020003442
pmid: 33570602
|
[2] |
Hu JQ, Geng YD, Ma JY, et al. The best evidence for the prevention and management of lower extremity deep venous thrombosis after gynecological malignant tumor surgery: A systematic review and network meta-analysis[J]. Front Surg, 2022, 9:841275.
doi: 10.3389/fsurg.2022.841275
|
[3] |
Giustozzi M, Curcio A, Weijs B, et al. Variation in the association between antineoplastic therapies and venous thromboembolism in patients with active cancer[J]. Thromb Haemost, 2020, 120(5):847-856.
doi: 10.1055/s-0040-1709527
|
[4] |
Mulder FI, Horváth-Puhó E, van Es N, et al. Venous thromboembolism in cancer patients: A population-based cohort study[J]. Blood, 2021, 137(14):1959-1969.
doi: 10.1182/blood.2020007338
pmid: 33171494
|
[5] |
Haen P, Mege DE, Crescence L, et al. Thrombosis risk associated with head and neck cancer: A review[J]. Int J Mol Sci, 2019, 20(11):2838.
doi: 10.3390/ijms20112838
|
[6] |
Key NS, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update[J]. J Clin Oncol, 2020, 38(5):496-520.
doi: 10.1200/JCO.19.01461
pmid: 31381464
|
[7] |
Chopard R, Albertsen IE, Piazza G. Diagnosis and treatment of lower extremity venous thromboembolism: A review[J]. JAMA, 2020, 324(17):1765-1776.
doi: 10.1001/jama.2020.17272
pmid: 33141212
|
[8] |
Campello E, Spiezia L, Adamo A, et al. Thrombophilia, risk factors and prevention[J]. Expert Rev Hematol, 2019, 12(3):147-158.
doi: 10.1080/17474086.2019.1583555
pmid: 30773075
|
[9] |
Khorana AA, Dalal M, Lin J, et al. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States[J]. Cancer, 2013, 119(3):648-655.
doi: 10.1002/cncr.27772
pmid: 22893596
|
[10] |
Mahajan A, Wun T, Chew H, et al. Lymphoma and venous thromboembolism: Influence on mortality[J]. Thromb Res, 2014, 133(Suppl 2):S23-S28.
|
[11] |
Marks MA, Engels EA. Venous thromboembolism and cancer risk among elderly adults in the United States[J]. Cancer Epidemiol Biomarkers Prev, 2014, 23(5):774-783.
doi: 10.1158/1055-9965.EPI-13-1138
|
[12] |
Park LC, Woo SY, Kim S, et al. Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: Results from a prospective cohort study with Asian population[J]. Thromb Res, 2012, 130(3):e6-e12.
doi: 10.1016/j.thromres.2012.03.019
|
[13] |
朱墨, 金萬勇, 朱载瓯, 等. 围手术期凝血指标与口腔颌面部游离皮瓣相关并发症间的关系[J]. 口腔医学, 2021, 41(6):521-526.
|
[14] |
Tang X, Li YY, Tian X, et al. Predicting severe acute radiation pneumonitis in patients with non-small cell lung cancer receiving postoperative radiotherapy: Development and internal validation of a nomogram based on the clinical and dose-volume histogram parameters[J]. Radiother Oncol, 2019, 132:197-203.
doi: S0167-8140(18)33540-0
pmid: 30385172
|
[15] |
孙沫逸, 郭伟, 冉炜, 等. 口腔颌面外科围手术期静脉血栓栓塞症评估与预防专家共识[J]. 实用口腔医学杂志, 2021, 37(3):293-302.
|
[16] |
刘东婷, 冯莹. 临床评分量表对预警院内深静脉血栓形成防治体系的临床价值[J]. 中华临床实验室管理电子杂志, 2021, 9(1):12-18.
|
[17] |
Gandaglia G, Ploussard G, Valerio M, et al. A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies[J]. Eur Urol, 2019, 75(3):506-514.
doi: S0302-2838(18)30753-X
pmid: 30342844
|
[18] |
Rose PG, Java J, Whitney CW, et al. Nomograms predicting progression-free survival, overall survival, and pelvic recurrence in locally advanced cervical cancer developed from an analysis of identifiable prognostic factors in patients from NRG oncology/gynecologic oncology group randomized trials of chemoradiotherapy[J]. J Clin Oncol, 2015, 33(19):2136-2142.
doi: 10.1200/JCO.2014.57.7122
pmid: 25732170
|
[19] |
张宇清. 微量白蛋白尿在高血压患者心血管风险评估中的价值[J]. 中华高血压杂志, 2019, 27(6):585-590.
|
[20] |
Tritschler T, Kraaijpoel N, Le Gal G, et al. Venous thromboembolism: Advances in diagnosis and treatment[J]. JAMA, 2018, 320(15):1583-1594.
doi: 10.1001/jama.2018.14346
pmid: 30326130
|
[21] |
Tham T, Rahman L, Persaud C, et al. Venous thromboembolism risk in head and neck cancer: Significance of the preoperative platelet-to-lymphocyte ratio[J]. Otolaryngol Head Neck Surg, 2018, 159(1):85-91.
doi: 10.1177/0194599818756851
pmid: 29406795
|
[22] |
Abboud WA, Hassin-Baer S, Alon EE, et al. Restricted mouth opening in head and neck cancer: Etiology, prevention, and treatment[J]. JCO Oncol Pract, 2020, 16(10):643-653.
doi: 10.1200/OP.20.00266
pmid: 33049177
|
[23] |
Li R, Yin YM, Cai XL, et al. Effect of routine inflammatory markers on clinical outcomes in acute basilar artery occlusion after endovascular thrombectomy: Results from ATTENTION registry[J]. Int J Stroke, 2023, 18(8):976-985.
doi: 10.1177/17474930231176948
|